| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 63.29B | 62.99B | 62.70B | 66.68B | 64.61B | 50.61B |
| Gross Profit | 10.31B | 10.26B | 10.03B | 10.54B | 11.35B | 8.64B |
| EBITDA | 4.97B | 4.36B | 4.80B | 5.69B | 6.02B | 4.08B |
| Net Income | 1.59B | 1.17B | 1.53B | 2.43B | 2.60B | 1.37B |
Balance Sheet | ||||||
| Total Assets | 51.66B | 50.66B | 50.80B | 46.73B | 46.65B | 39.96B |
| Cash, Cash Equivalents and Short-Term Investments | 245.00M | 338.00M | 241.00M | 214.00M | 411.00M | 198.00M |
| Total Debt | 11.46B | 8.00B | 10.89B | 7.97B | 11.09B | 7.60B |
| Total Liabilities | 22.84B | 20.47B | 22.37B | 22.40B | 23.95B | 18.90B |
| Stockholders Equity | 28.82B | 30.19B | 28.42B | 24.33B | 22.70B | 21.06B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.29B | -1.83B | 3.72B | -3.13B | -2.38B |
| Operating Cash Flow | 0.00 | 6.86B | 3.69B | 6.77B | -533.00M | 292.00M |
| Investing Cash Flow | 0.00 | -3.06B | -5.76B | -2.46B | -2.24B | -2.41B |
| Financing Cash Flow | 0.00 | -3.70B | 2.10B | -4.51B | 2.98B | 2.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥15.40B | 10.26 | ― | 1.74% | 7.50% | 86.59% | |
63 Neutral | ¥19.21B | 32.22 | ― | 2.98% | 0.47% | -23.39% | |
63 Neutral | ¥13.73B | 30.36 | ― | 2.16% | -1.43% | 43.68% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥35.00B | 4.55 | ― | 0.80% | 12.41% | 129.01% | |
48 Neutral | ¥14.10B | 51.12 | ― | 1.61% | 2.00% | -44.01% | |
46 Neutral | ¥34.17B | 21.75 | ― | 1.65% | -1.17% | -95.57% |